The silent epidemic: Tobacco and the evolution of lung cancer and its treatment

Cancer Investigation

Volumn 19, Issue 7, 2001, Pages 739-751

  Cooley, Mary E ^a   Kaiser, Larry R ^b   Abrahm, Janet L ^c   Giarelli, Ellen ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lung cancer and quality of life; Lung cancer treatment; Tobacco control

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; CIGARETTE SMOKING; EPIDEMIC; HUMAN; LUNG CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING CESSATION; TOBACCO;

COST OF ILLNESS; DISEASE OUTBREAKS; HEALTH POLICY; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; QUALITY OF LIFE; SMOKING; SMOKING CESSATION; SOCIAL CONDITIONS; TOBACCO INDUSTRY; UNITED STATES;

EID: 0034811205     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-100106149     Document Type: Article

References (117)

1. Cancer statistics, 1999
2. Ausgedehnte lungenresection wegen zahlreicher eiternder bronchectasieen in einem unterlappen
3. Zur pathologie des offenen pneumothorax und die grundlagen meines verfahrens zu seiner ausschaltung. Mitt grenzge
4. A half century of effort to control cancer: An appraisal of the problem and an estimation of accomplishments
5. Continuous respiration without respiratory movements
6. A new intratracheal cannula
7. A new anesthetic gas: Cyclopropane
8. Induction of anesthesia in man by intravenous injection of sodium isoamylethyl barbiturate
9. Power of one: Nurses and tobacco control
10. The development of pulmonary surgery
11. Successful removal of an entire lung for carcinoma of the bronchus
12. A single cervicomediastinal exploration for tissue diagnosis of intrathoracic disease
13. Mediastinoscopy: A method for inspection and tissue biopsy in the superior mediastinum
14. Roentgenotherapy of malignant bronchial and pulmonary tumors: Further experiences
15. Radiotherapy of cancer of the lung
16. Nitrogen mustard as an adjunct to radiation in the management of bronchogenic cancer
17. Oat cell carcinoma of the bronchus
18. Symposium on cancer. Primary pulmonary malignancy. Treatment by total pneumonectomy, analysis of 79 collected cases and presentation of 7 personal cases
19. A study of the etiology of carcinoma of the lung
20. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma: A study of six hundred and eighty four proved cases
21. The quiet victory of the cigarette lobby: How it beat the best filter yet - Congress
22. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer
23. Historic background of the Lung Cancer Study Group
24. Introduction: LCSG - The final analysis
25. What were the issues of surgical importance in lung cancer treatment in 1977? How did they change over time?
26. The role of chemotherapy in the treatment of small cell lung cancer
27. Alkylating agents in bronchogenic carcinoma
28. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine
29. The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma
30. Small cell bronchogenic carcinoma: A review of therapeutic responses
31. The epidemiology of lung cancer in women
32. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females
33. Genetic and molecular changes of human lung cancer
34. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
35. Early lung cancer action project: Overall design and findings from baseline screening
36. Early detection and prevention of lung cancer
37. Non small cell lung cancer
38. Small cell lung cancer
39. Food and drug administration requirements for approval of new anticancer drugs
40. Quality of life: Concepts and definitions
41. Comparison of instruments for measuring quality of life in patients with lung cancer
42. NCCN small cell lung cancer practice guidelines
43. NCCN non-small cell lung cancer practice guidelines
44. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer
45. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only: A Muticentre randomized phase III trial: Joint Lung Cancer Study Group
46. Polychemotherapy in advanced non-small cell lung cancer: A meta-analysis
47. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: Best supportive care versus best supportive care plus chemotherapy
48. Management of cancer pain
49. Radiation for bone metastasis: Conventional techniques and the role of systemic radiopharmaceuticals
50. A prospective, randomized double blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
51. Unsealed source therapy of painful bone metastasis: An update
52. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double blind placebo-controlled trial
53. Current use of biphosphonates in oncology, International Bone and Cancer Study Group
54. High dose pamidronate: Clinical and biochemical effects in metastatic bone disease
55. Treatment of cancer associated hypercalcemia: Double blind comparison of rapid and slow intravenous regiments of pamidronate sodium and saline alone
56. Neurological problems
57. Palliative radiation therapy
58. Management of pain and spinal cord compression in patients with advanced cancer
59. Palliation of respiratory symptoms
60. Hemoptysis
61. Multicentre randomized trial of nursing intervention for breathlessness in patients with lung cancer
62. Non-pharmacological intervention for breathlessness in lung cancer
63. Dyspnea: Pathophysiology and assessment
64. Management of dyspnea and cough in patients with cancer
65. Nebulized lidocaine in the treatment of refractory cough
66. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for treatment of cancer anorexia/cachexia
67. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double blind study
68. Impact of therapy with epoietin alpha on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice
69. Health policy and the politics of health care
70. Costs and coverage: Pressures toward health reform
71. Quality of life and cost effectiveness assessment in lung cancer
72. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized clinical trial in non-small cell lung cancer
73. Cost-effectiveness and palliative care
74. Biases in quantitative measurement of values for public decisions
75. Trading treatment toxicity for survival in advanced non-small cell lung cancer
76. Decision analysis in locally advanced non-small cell lung cancer: Is it useful?
77. Cost-utility analysis
78. Cost utility of chemotherapy and best supportive care in non-small cell lung cancer
79. Methods for quality adjustment of life years
80. The human costs of tobacco use
81. Cigarette smoking and health policy
82. The human costs of tobacco use
83. Socioeconomic factors and racial smoking differences in the United States
84. Trends in cigarette smoking in the United States: Educational differences are increasing
85. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
86. Legislative efforts to protect children from tobacco
87. The illegal sale of cigarettes to US minors: Estimates by state
88. Cancer statistics for African Americans, 1996
89. Epidemiology of lung cancer
90. Smoking foes fume over use of payments: Health campaigns often take a back seat
91. Tobacco settlement attacked again. Black physician's group believes the proposal is weak
92. Preventing tobacco-caused cancer: A call to action
93. Operable lung cancer